Response to everolimus of a progressive plexiform neurofibroma in Neurofibromatosis type 1

Saved in:
Bibliographic Details
Published in:Pediatrics international 2020-07, Vol.62 (7), p.857-859
Main Authors: Mateos, Maria Elena, López‐Laso, Eduardo, Vicente, Josefina, Ortega, Rosa, Vázquez, Fernando, Pérez‐Navero, Juan Luis
Format: Article
Language:English
Subjects:
Antineoplastic Agents - therapeutic use
Child
everolimus
Everolimus - therapeutic use
Female
Genetic disorders
Humans
Magnetic Resonance Imaging - methods
mammalian target of rapamycin
Neurofibroma, Plexiform - complications
Neurofibroma, Plexiform - drug therapy
Neurofibromatosis
Neurofibromatosis 1 - complications
Neurofibromatosis 1 - drug therapy
neurofibromatosis type 1
Neurological disorders
Pediatrics
Plexiform neurofibroma
Recklinghausen's disease
therapeutics
TOR Serine-Threonine Kinases - metabolism
Treatment Outcome
Tumors
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:1328-8067
1442-200X
DOI:10.1111/ped.14183